Sodium Bicarbonate 8 — Class II drug recall D-1075-2017
Terminated recall by Cantrell Drug Company, reported 2017-08-16, distributed nationwide. Lack of Sterility Assurance.
| Recall number | D-1075-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cantrell Drug Company, Little Rock, AR, United States |
| Recall initiated | 2017-07-14 |
| Classified | 2017-08-09 |
| Reported by FDA | 2017-08-16 |
| Terminated | 2020-09-16 |
| Distributed | Nationwide (US) |
| Quantity | 40,081 syringes |
| Reason classes | sterility |
| Lot numbers | 10349, 10356, 10377, 10386, 10394, 10404, 10423, 10468, 10473, 10482, 10514, 10524, 10569 |
| Expiration dates | 2017-07-30, 2017-07-31, 2017-08-04, 2017-08-05, 2017-08-06, 2017-08-08, 2017-08-12, 2017-08-18, 2017-08-19, 2017-08-20, 2017-08-25, 2017-08-26, 2017-09-03 |
Product
Sodium Bicarbonate 8.4% Injection Solution 50 mL, 50 mEq (1mEq/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222
Reason for recall
Lack of Sterility Assurance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1075-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.